Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts.
- DOI
- 10.1016/j.omton.2024.200820
- Published
- 2024 Jun 20
- Container
- Molecular therapy. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omton.2024.200820,
title = {Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts.},
author = {Chu Y and Nayyar G and Tian M and Lee DA and Ozkaynak MF and Ayala-Cuesta J and Klose K and Foley K and Mendelowitz AS and Luo W and Liao Y and Ayello J and Behbehani GK and Riddell S and Cripe T and Cairo MS},
year = {2024},
journal = {Molecular therapy. Oncology},
doi = {10.1016/j.omton.2024.200820},
url = {https://doi.org/10.1016/j.omton.2024.200820}
}RIS
TY - JOUR TI - Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts. AU - Chu Y AU - Nayyar G AU - Tian M AU - Lee DA AU - Ozkaynak MF AU - Ayala-Cuesta J AU - Klose K AU - Foley K AU - Mendelowitz AS AU - Luo W AU - Liao Y AU - Ayello J AU - Behbehani GK AU - Riddell S AU - Cripe T AU - Cairo MS PY - 2024 JO - Molecular therapy. Oncology DO - 10.1016/j.omton.2024.200820 UR - https://doi.org/10.1016/j.omton.2024.200820 ER -
APA
Y, C., G, N., M, T., DA, L., MF, O., J, A., K, K., K, F., AS, M., W, L., Y, L., J, A., GK, B., S, R., T, C., & MS, C. (2024). Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2024.200820
Source records
- pubmed · retrieved 2026-09-26T00:36:12.389Z
- europe-pmc · retrieved 2026-09-26T00:36:12.393Z
- doaj · retrieved 2026-09-26T00:36:12.424Z